🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-06-03
Trial ID
NCT04373460
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of allogen...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2025-07-20
Trial ID
NCT07126782
Treatments Being Tested
Efficacy of immunoadsorption for treatment of persons with Alzheimer dement...
Status
Terminated
Location
University Medicine Greifswald
Start Date
2016-09-15
Trial ID
NCT03132272
Treatments Being Tested
The objective of this study is to test the hypothesis that INTERCEPT platel...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02310412
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of targeted i...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01508910
Treatments Being Tested
This is a phase I, prospective clinical trial studying the safety and feasi...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2025-09-25
Trial ID
NCT07052370
The proposed clinical study is a Phase 1/2a trial to investigate the safety...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-06-21
Trial ID
NCT05672459
This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Start Date
2025-09-01
Trial ID
NCT07117305
Treatments Being Tested
Primary Objective: To evaluate the effect of caplacizumab on prevention of...
Status
Completed
Location
Investigational Site Number 3920009
Start Date
2019-10-21
Trial ID
NCT04074187